Trial Profile

The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 25 Jul 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Efinaconazole (Primary)
Indications Onychomycosis
Focus Registrational; Therapeutic Use
Sponsors Dow Pharmaceutical Sciences

Most Recent Events

13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
01 Apr 2017 Results of post-hoc pooled analysis comparing data for Latino (n=270) versus non-Latino populations (n=1380) of the two pivotal studies (NCT01007708 and NCT01008033), published in the Cutis Journal.
05 Jun 2014 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com